Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004153 (
atherosclerosis
)
77,401
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Endothelial hyper-permeability is a major determinant factor that contributes to the accelerated development of atherosclerotic lesions at hemodynamically disturbed sites. Previously, we showed that C1q/TNF related protein (CTRP) 1 promotes endothelium-leukocyte interactions and inflammatory responses in vascular cells. Here, we sought to investigate the role of
CTRP1
in modulation of endothelial permeability under disturbed flow condition. By using en face staining of mouse aorta, we found
CTRP1
expression was significantly increased in vascular endothelial cells under disturbed flow as compared to steady laminar flow. Vascular permeability to Evans blue dye was notably enhanced in
CTRP1
knockin mice as compared to wild type animals, whereas aortic hyper-permeability at disturbed sites was remarkably restored after deletion of
CTRP1
. In cultured endothelial cells, treatment of
CTRP1
led to increased permeability to fluorescent-labelled dextran and apparent formation of paracellular holes as observed after disturbed flow exposure, which was evidently reduced in the presence of a
CTRP1
-specific neutralizing antibody. Mechanistically, we found activation of VEGFR2 by
CTRP1
might be involved in vascular hyper-permeability under disturbed flow condition. Taken together, this study suggests that
CTRP1
is a mechano-sensitive proinflammatory factor that mediates disturbed flow-induced vascular barrier dysfunction. Inhibition of
CTRP1
may inhibit the pathogenesis of
atherosclerosis
at early stage.
...
PMID:C1q/TNF-related protein 1 promotes endothelial barrier dysfunction under disturbed flow. 2862 19